CGP77675 is a potent inhibitor of Src family kinases with antitumor activity; it inhibits Src, EGFR, KDR, v-Abl, and Lck with IC50 values of 0.02, 0.15, 1.0, 0.31, and 0.29 μM, respectively; it suppresses tyrosine phosphorylation of Src substrates such as Fak and paxillin; it inhibits parathyroid hormone-induced bone resorption in rat fetal long bone cultures (IC50 = 0.8 μM); it prevents IL-1β-induced hypercalcemia in mice; and it partially prevents bone loss and rescues bone microarchitectural features in ovariectomized rats.